tiprankstipranks

Matthew Posard Insider Profile

4 Followers
Matthew Posard, CCO at Cardiff Oncology, holds 158.22K shares in DermTech (Ticker: DMTK), holds 113.25K shares in Halozyme (Ticker: HALO), holds 150.00K shares in Nautilus Biotechnolgy (Ticker: NAUT).
tipranks
Matthew Posard

Matthew Posard
Cardiff Oncology (CRDF)
CCO

Ranked #28,398 out of 97,825 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+7.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
45.85%
42.54%
5.51%
4.13%
1.97% Others
A breakdown of Matthew Posard's holdings

Insider Roles

Halozyme
(HALO)
Director
Illumina
(ILMN)
Sr VP & General Manager
Talis Biomedical
(TLIS)
Director
Nautilus Biotechnolgy
(NAUT)
Director
+2 other positions
Roles that Matthew Posard holds in companies

Most Profitable Insider Trade

Stock:
DermTech
(DMTK)
Rating:Informative Buy
Date:May 01, 2020 - May 01, 2021
Return:+222.90%
The most profitable trade made by Matthew Posard

Matthew Posard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cardiff Oncology
Aug 24, 2015
CCO
Uninformative Buy
$86.25K
DermTech
Jun 05, 2023
Director
Uninformative Buy
$112.17K
Talis Biomedical
Feb 19, 2021
Director
Informative Buy
1.00M
$554.69K
Nautilus Biotechnolgy
Dec 01, 2021
Director
Informative Buy
225.40K
$415.50K
Halozyme
May 09, 2023
Director
Uninformative Buy
$4.61M
Illumina
May 30, 2013
Sr VP & General Manager
Uninformative Sell
200.79K
$4.28M
List of latest transactions for each holding click on a transaction to see Matthew Posard's performance on stock

Matthew Posard insider profile FAQ

What is the percentage of profitable transactions made by Matthew Posard?
The percentage of profitable transactions made by Matthew Posard is 40%.
    What is the average return per transaction made by Matthew Posard?
    The average return per transaction made by Matthew Posard is 7.60%.
      What stocks does Matthew Posard hold?
      Matthew Posard holds: CRDF, DMTK, TLIS, NAUT, HALO, ILMN stocks.
        What was Matthew Posard’s latest transaction?
        Matthew Posard latest transaction was an Uninformative Buy of ―.
          What was Matthew Posard's most profitable transaction?
          Matthew Posard’s most profitable transaction was an Informative Buy of DMTK stock on May 1, 2020. The return on the trade was 222.90%.
            What is Matthew Posard's role in Cardiff Oncology?
            Matthew Posard's role in Cardiff Oncology is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.